Publicacions en què col·labora amb Jesús García Mata (9)

2021

  1. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255

2020

  1. The economic burden of metastatic breast cancer in Spain

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24

2010

  1. Current controversies in the management of breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 4, pp. 278-286

  2. Erratum: Current controversies in the management of breast cancer (Clinical and Translational Oncology 12:4 (278-286))

    Clinical and Translational Oncology

  3. Supportive care for patients with early breast cancer

    Clinical and Translational Oncology, Vol. 12, Núm. 1, pp. 32-42

2007

  1. Advanced breast cancer: Chemotherapy phase III trials that change a standard

    Anti-Cancer Drugs

  2. Current controversies in the management of early breast cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384

  3. The use of taxanes in the neoadjuvant treatment of breast cancer: A review of randomized phase II/III trials

    Clinical Breast Cancer, Vol. 7, Núm. 10, pp. 764-774

2004

  1. Experiencia del Hospital Universitario de Salamanca en el tratamiento sistémico adyuvante del cáncer de mama locorregional. Resultados de un protocolo asistencial tras 7 años de seguimiento

    Oncología, Vol. 27, Núm. 3, pp. 28-38